Tempus AI (TEM) Stock Price Today
Anteris gets German clearance to expand global PARADIGM heart valve trial, boosting patient recruitment.
Anteris Technologies received regulatory approval from Germany's BfArM to start enrolling patients in its global PARADIGM trial for the DurAVR Transcatheter Heart Valve. This approval allows the company to recruit patients at leading German centers, ...
Oil prices rise on Middle East supply risks despite potential Russian export boost
Brent crude oil prices recovered to around $109.78 per barrel amid renewed concerns over supply disruptions in the Middle East, following unconfirmed attacks on Saudi energy sites by Yemen’s Houthis. The risk of supply interruptions in the Gulf remai...
Phase II study shows Vilamakitug improves 12-month survival in refractory metastatic colorectal cancer.
XBiotech announced positive final results from the Phase II TASKIN study, showing that adding Vilamakitug (XB2001) to standard chemotherapy improved 12-month overall survival to 61.3% in patients with refractory metastatic colorectal cancer, surpassi...
Jio Platforms' IPO anchor book oversubscribed 30x with $26.3B bids from top global investors
Jio Platforms, backed by Meta and Google, has seen its IPO anchor book oversubscribed over 30 times, attracting $26.3 billion in bids for an $854 million portion. The company aims to raise up to $3.2 billion in India's largest-ever IPO by rupee value...
Anteris Technologies gains German approval to expand PARADIGM heart valve trial in Europe.
Anteris Technologies has received full regulatory clearance from Germany to expand its PARADIGM trial for the DurAVR transcatheter heart valve, targeting patients with severe calcific aortic stenosis. This approval allows the company to recruit patie...
Nvidia commits nearly $10B to boost Europe's AI, backing four German startups and partnering with German industry.
Nvidia announced a nearly $10 billion investment plan to support Europe's AI ecosystem, focusing on four German startups: Agile Robots, Avelios Medical, Mirelo, and Reflex Aerospace. This move aligns with Germany's goal to lead in industrial AI, with...
Recce Pharmaceuticals advances Phase 3 trial for diabetic foot infection with positive safety and efficacy signals.
Recce Pharmaceuticals has reached a key milestone in its Phase 3 trial for treating diabetic foot infections with its RECCE® 327 Gel (R327G). An independent Data Monitoring Committee will review unblinded data from 75 patients, following encouraging ...
Flipkart enters India's food delivery market to challenge Zomato and Swiggy with lower commissions.
Flipkart, owned by Walmart, is launching a food delivery service in India to compete against dominant players Zomato and Swiggy. The company is currently testing the service internally in Bengaluru with plans for a public launch by October and expans...
US Vice President JD Vance declines to endorse Netanyahu despite Trump's support ahead of Israeli election.
US Vice President JD Vance has chosen not to endorse Israeli Prime Minister Benjamin Netanyahu in the upcoming election, diverging from President Donald Trump's public backing of Netanyahu. Vance emphasized his focus on endorsing American candidates ...
Socialism gains political ground in US, prompting free market advocates to strengthen their case for capitalism.
Socialism is rising in popularity within U.S. politics, particularly among those identifying as democratic socialists who seek a system more like European social democracy. Sam Gregg of the American Institute for Economic Research highlights the need...
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.